Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.08% Nasdaq Down 0.83%
Streaming
Ticker Tape: On

More On LRUSF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Lorus Therapeutics Inc. (LRUSF)

-Other OTC
0.50 Up 0.00(0.40%) 3:01PM EDT
Get the big picture on all your investments.
Prev Close:0.50
Open:0.50
Bid:N/A
Ask:N/A
1y Target Est:1.82
Beta:-0.11
Next Earnings Date:N/A
Day's Range:0.50 - 0.50
52wk Range:0.16 - 0.93
Volume:4,350
Avg Vol (3m):14,555
Market Cap:56.36M
P/E (ttm):N/A
EPS (ttm):-0.17
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for LRUSF at this time.

Reports

Comparison

Symbol% ChgMkt Cap
LRUSFUp 0.40%56.36M
BMYDown 0.08%84.08B
ISISDown 4.86%4.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (May-14) :-0.07
Quarterly EPS Est (May-14) :-0.02
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lorus Therapeutics Inc., a biopharmaceutical company, engages in the discovery, research, and development of novel anticancer therapies in Canada. Its product pipeline includes LOR-253, an anticancer agent for the treatment of human cancers, inclu... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback